SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Guggenheim Keeps Tenet Healthcare at Buy, Cuts Target to $306

Guggenheim maintained its Buy rating and lowered its price target to $306 from $307.

THC

Related stories